Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Account Payables (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Change in Account Payables for 16 consecutive years, with -$399000.0 as the latest value for Q3 2025.

  • Quarterly Change in Account Payables fell 130.57% to -$399000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Sep 2025, down 151.68% year-over-year, with the annual reading at $1.0 million for FY2024, 65.34% down from the prior year.
  • Change in Account Payables for Q3 2025 was -$399000.0 at Xtant Medical Holdings, down from $10000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $1.7 million in Q4 2023, with the low at -$890000.0 in Q1 2025.
  • Average Change in Account Payables over 5 years is $172473.7, with a median of $151000.0 recorded in 2021.
  • The sharpest move saw Change in Account Payables surged 813.04% in 2024, then crashed 280.89% in 2025.
  • Over 5 years, Change in Account Payables stood at $260000.0 in 2021, then crashed by 211.15% to -$289000.0 in 2022, then surged by 682.01% to $1.7 million in 2023, then tumbled by 115.28% to -$257000.0 in 2024, then tumbled by 55.25% to -$399000.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$399000.0, $10000.0, and -$890000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.